Application Nr Approved Date Route Status External Links
NDA020505 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Topamax ® Is Indicated For: Epilepsy: Initial Monotherapy For The Treatment Of Partial-Onset Or Primary Generalized Tonic-Clonic Seizures In Patients 2 Years Of Age And Older ( 1.1 ); Adjunctive Therapy For The Treatment Of Partial-Onset Seizures, Primary Generalized Tonic-Clonic Seizures, Or Seizures Associated With Lennox-Gastaut Syndrome In Patients 2 Years Of Age And Older ( 1.2 ) Preventive Treatment Of Migraine In Patients 12 Years Of Age And Older ( 1.3 ) 1.1 Monotherapy Epilepsy Topamax ® Is Indicated As Initial Monotherapy For The Treatment Of Partial-Onset Or Primary Generalized Tonic-Clonic Seizures In Patients 2 Years Of Age And Older. 1.2 Adjunctive Therapy Epilepsy Topamax ® Is Indicated As Adjunctive Therapy For The Treatment Of Partial-Onset Seizures, Primary Generalized Tonic-Clonic Seizures, And Seizures Associated With Lennox-Gastaut Syndrome In Patients 2 Years Of Age And Older. 1.3 Migraine Topamax ® Is Indicated For The Preventive Treatment Of Migraine In Patients 12 Years Of Age And Older.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Topiramate TOPIRAMATE ZINC95616603

Comments